Company Filing History:
3 out of 343 
2 out of 4 
2 out of 21 
Years Active: 2011-2024
Title: Luigina Romani: Innovator in Cystic Fibrosis Treatment
Introduction
Luigina Romani is a prominent inventor based in Perugia, Italy, known for her significant contributions to the field of medical research, particularly in the treatment of cystic fibrosis. With a total of 11 patents to her name, she has made remarkable strides in developing innovative therapies that address this challenging condition.
Latest Patents
Among her latest patents is the use of Thymosin alpha 1 (Tα1) for the treatment of cystic fibrosis. This invention focuses on Thymosin alpha 1 as a CFTR corrector, CFTR potentiator, and anti-inflammatory agent, showcasing her commitment to advancing therapeutic options for patients suffering from this disease.
Career Highlights
Throughout her career, Luigina has worked with notable companies such as Sigma-Tau Industrie Farmaceutiche Riunite S.p.a. and Sciclone Pharmaceuticals International, Ltd. Her work in these organizations has allowed her to develop and refine her innovative ideas, contributing to the advancement of medical treatments.
Collaborations
Luigina has collaborated with esteemed colleagues, including Enrico Garaci and Francesco Bistoni, further enhancing her research and development efforts in the medical field.
Conclusion
Luigina Romani's dedication to innovation in cystic fibrosis treatment exemplifies her role as a leading inventor in the medical research community. Her contributions continue to impact the lives of many patients, highlighting the importance of ongoing research and development in healthcare.